Clinical Trials Detalhe

Randomized, Double-Blind, Placebo-Controlled Trial Of Pregabalin In Patients With Fibromyalgia.

General Information

Gender

ALL

Age

N/A

Phase

PHASE3

Study Type

INTERVENTIONAL

Location

Pfizer Investigational Site (Lisbon, Portugal)

Clinicaltrial.gov

https://classic.clinicaltrials.gov/ct2/show/NCT00333866

Summary

This study, will compare pregabalin with placebo for the duration of 14 weeks to evaluate the efficacy and safety of pregabalin in patients with fibromyalgia.

Conditions

Fibromyalgia

Eligibility

Inclusion Criteria: * ACR criteria for fibromyalgia * A score of more or equal to 40 mm on the Pain Visual Analog Scale (VAS) and a an average score more or equal to 4 on 4 daily pain diaries Exclusion Criteria: * Patients with other severe pain conditions * Patients with severe depression * Patients taking excluded medications